本季度信息
瑞丽医美（02135）公布截至2026年6月30日止六个月业绩，营收约为1.15亿元人民币，同比上升35.7%。毛利率约为38.4%，较上一年同期的34.4%有所提升。销售及分销开支约占营收的19.48%，行政开支约占营收的12.54%，研发投入占比约1.2%。经营成本结构中，所出售存货成本较上年同期大幅上升，主要源于医疗美容器械产品销量增加。
业务分项
医美服务收入约0.78亿元，同比上升4.5%。其中，微创美容服务增长9.7%，皮肤美容服务增长2.9%，美容外科服务则有所下滑。医疗美容器械产品销售收入约0.36亿元，同比增幅达289.9%，主要得益于胶原注射产品的销售规模扩大，医美机构开户数与认证医生数量同步增加。
高管解读
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.